Vemurafenib - PDFSEARCH.IO - Document Search Engine

Vemurafenib
Results: 105

#	Item
11	Zelboraf, INN - vemurafenib Add to Reading List Source URL: www.ema.europa.eu Language: Danish - Date: 2014-08-05 06:58:15
12	Microsoft WordDabrafenib GSK PSD March 13 final...docx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:23 Melanoma Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Ipilimumab Dacarbazine End point of clinical trials Medicine Chemistry Oncology
13	Microsoft WordVemurafenib Roche PSD MArch 2013 FINAL.doc Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:23 Amides Organochlorides Organofluorides Sulfonamides Vemurafenib Melanoma BRAF Ipilimumab Dacarbazine Medicine Chemistry Pharmacology
14	What Is Personalized Medicine? Personalized medicine is the tailoring of medical treatment to the individual characteristics of each patient. The approach relies on scientific breakthroughs in our understanding of how a Add to Reading List Source URL: www.ageofpersonalizedmedicine.org Language: English - Date: 2013-07-19 10:24:33 Genetics Personalized medicine Pharmacology Trastuzumab Melanoma Breast cancer Vemurafenib BRAF Targeted therapy Medicine Biology Evidence-based medicine
15	July 22, 2013 Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models Data Presented at 8th Wor Add to Reading List Source URL: astx.com Language: English Organofluorides Alkynes Melanoma Organochlorides Vemurafenib Hsp90 Astex Targeted therapy Erlotinib Chemistry Organic chemistry Medicine
16	Health Care in the Era of Personalized Medicine: An Industry Perspective Andreas Wallnoefer Pharma Research & Early Development F. Hoffmann-La Roche Ltd. Add to Reading List Source URL: www.swisstph.ch Language: English - Date: 2014-12-17 06:35:36 Organochlorides Organofluorides Oncology Trastuzumab HER2/neu Breast cancer Personalized medicine Vemurafenib Phosphoinositide 3-kinase Medicine Biology Ribbon symbolism
17	BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy Add to Reading List Source URL: www.nature.com Language: English - Date: 2012-01-19 07:56:45 Oncogenes Organochlorides Organofluorides BRAF Sorafenib Hepatocellular carcinoma Vemurafenib Ras subfamily Melanoma Medicine Chemistry Oncology
18	Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS Add to Reading List Source URL: www.nature.com Language: English - Date: 2010-09-02 07:06:55 Programmed cell death T cells RNA splicing Bcl-2 Messenger RNA Melanoma Vemurafenib Alternative splicing C-Raf Biology Gene expression Apoptosis
19	Combining the HSP90 inhibitor, AT13387, with vemurafenib delays the emergence of V600E resistance in a preclinical model of BRAF mutant melanoma. Tomoko Smyth, Jon Lewis, Keisha Hearn, Neil Thompson, John Lyons, Mohammad Add to Reading List Source URL: astx.com Language: English - Date: 2013-09-21 15:10:26 Chemistry Tyrosine kinase inhibitors Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Hsp90 Melanoma Medicine Biology Oncogenes
20	AT13387, an HSP90 inhibitor, is effective in both vemurafenib-sensitive and -resistant melanoma models Ana M. Rodriguez-Lopez, Tomoko Smyth, Jayne Curry, Brent Graham, Rachel McMenamin, John Lyons, Neil Thompson & Nicola Add to Reading List Source URL: astx.com Language: English - Date: 2012-12-13 18:06:00 Oncogenes Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Hsp90 inhibitors AKT Hsp90 Medicine Chemistry Biology

UPDATE